Pharminent

Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar

Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar – Positive opinion based on a clinical development program involving over 1,000 people with type 1 or type 2 diabetes – .. http://www.euroinvestor.com/news/2017/05/19/sanofi-receives-chmp-recommendation-for-approval-of-insulin-lispro-biosimilar/13603431

Filed under: Biosimilar